These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28115511)

  • 21. Effects of renal sympathetic denervation on exercise blood pressure, heart rate, and capacity in patients with resistant hypertension.
    Ewen S; Mahfoud F; Linz D; Pöss J; Cremers B; Kindermann I; Laufs U; Ukena C; Böhm M
    Hypertension; 2014 Apr; 63(4):839-45. PubMed ID: 24420550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Endovascular renal denervation for drug-refractory hypertension : RADIANCE-HTN TRIO].
    Dörr O; Hamm C; Nitschmann S
    Internist (Berl); 2022 Jan; 63(1):129-132. PubMed ID: 34985564
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal denervation for the treatment of resistant hypertension: review and clinical perspective.
    Iliescu R; Lohmeier TE; Tudorancea I; Laffin L; Bakris GL
    Am J Physiol Renal Physiol; 2015 Oct; 309(7):F583-94. PubMed ID: 26224718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?
    Epstein M; de Marchena E
    J Am Soc Hypertens; 2015 Feb; 9(2):140-9. PubMed ID: 25649995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose sustained-release deoxycorticosterone acetate-induced hypertension in Bama miniature pigs for renal sympathetic nerve denervation.
    Han W; Fang W; Gan Q; Guan S; Li Y; Wang M; Gong K; Qu X
    J Am Soc Hypertens; 2017 May; 11(5):314-320. PubMed ID: 28411074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous renal sympathetic denervation: 2013 and beyond.
    Froeschl M; Hadziomerovic A; Ruzicka M
    Can J Cardiol; 2014 Jan; 30(1):64-74. PubMed ID: 24365191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long lasting effects of renal denervation: lights and shadows of the SPYRAL HTN-ON MED 3-year follow-up.
    Vergallo R; Volpe M
    Eur Heart J; 2022 Jul; 43(28):2655-2656. PubMed ID: 35653614
    [No Abstract]   [Full Text] [Related]  

  • 28. Renal Denervation.
    Hameed MA; Dasgupta I
    Adv Exp Med Biol; 2017; 956():261-277. PubMed ID: 27815927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Impact of renal denervation on expression of renalase and tyrosine hydroxylase in adult rats with spontaneous hypertension].
    Guo Y; Li L; Tan L; Tang X; Yang Q; Jiang W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):829-33. PubMed ID: 22954924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood pressure lowering effect of renal sympathetic denervation or placebo? - building expectations for Symplicity-HTN 3.
    Kjeldsen SE; Narkiewicz K; Oparil S; Hedner T
    Blood Press; 2013 Oct; 22(5):279-81. PubMed ID: 24059787
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal Denervation for Resistant Hypertension.
    Reilly JP; White CJ
    Prog Cardiovasc Dis; 2016; 59(3):295-302. PubMed ID: 27789315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal denervation for treatment of drug-resistant hypertension.
    Esler M
    Trends Cardiovasc Med; 2015 Feb; 25(2):107-15. PubMed ID: 25467242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal denervation attenuates NADPH oxidase-mediated oxidative stress and hypertension in rats with hydronephrosis.
    Peleli M; Al-Mashhadi A; Yang T; Larsson E; Wåhlin N; Jensen BL; G Persson AE; Carlström M
    Am J Physiol Renal Physiol; 2016 Jan; 310(1):F43-56. PubMed ID: 26538440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal denervation in the treatment of resistant hypertension: Dead, alive or surviving?
    Al-Fakhouri A; Efeovbokhan N; Nakhla R; Khouzam RN
    Rev Port Cardiol; 2016 Oct; 35(10):531-8. PubMed ID: 27614724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discontinuation of Therapy in Hypertension Research: Value, Ethics, Risk, and Role in Renal Denervation Trials.
    Elijovich F; Laffer CL
    Hypertension; 2017 May; 69(5):795-797. PubMed ID: 28373585
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension　- Insights From the SYMPLICITY HTN-3 Trial.
    Kario K; Bhatt DL; Kandzari DE; Brar S; Flack JM; Gilbert C; Oparil S; Robbins M; Townsend RR; Bakris G
    Circ J; 2016 May; 80(6):1404-12. PubMed ID: 27118620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges.
    Persu A; Kjeldsen S; Staessen JA; Azizi M
    Curr Hypertens Rep; 2016 Jan; 18(1):6. PubMed ID: 26739586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SPYRAL HTN-OFF MED study: Renal denervation in the spiral orbits of current results and future studies.
    Tsioufis C; Dimitriadis K; Papademetriou V; Tousoulis D
    Hellenic J Cardiol; 2017; 58(5):320-321. PubMed ID: 29056558
    [No Abstract]   [Full Text] [Related]  

  • 39. The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications.
    Kandzari DE; Kario K; Mahfoud F; Cohen SA; Pilcher G; Pocock S; Townsend R; Weber MA; Böhm M
    Am Heart J; 2016 Jan; 171(1):82-91. PubMed ID: 26699604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistant Hypertension and Renal Nerve Denervation.
    Denker MG; Cohen DL
    Methodist Debakey Cardiovasc J; 2015; 11(4):240-4. PubMed ID: 27057294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.